Kazia Therapeutics (KZIA) Long-Term Investments (2016 - 2019)

Kazia Therapeutics' Long-Term Investments history runs 4 years deep, the most recent figure standing at $114648.7 for Q4 2019.

• Quarterly Long-Term Investments fell 94.19% year-over-year to $114648.7 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $114648.7 (down 94.19% YoY) and the FY2019 annual result came in at $117679.3, down 96.41% from the prior year.
• Long-Term Investments was $114648.7 for Q4 2019 at Kazia Therapeutics, down from $117679.3 in the prior quarter.
• Across five years, Long-Term Investments topped out at $5.8 million in Q4 2016 and bottomed at $16280.4 in Q2 2016.
• A 4-year average of $1.6 million and a median of $117679.3 in 2019 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2018 — Long-Term Investments jumped 19757.38% — and 2019, when it tumbled 96.41%.
• Kazia Therapeutics' Long-Term Investments stood at $5.8 million in 2016, then slumped by 99.72% to $16526.6 in 2017, then jumped by 11839.25% to $2.0 million in 2018, then slumped by 94.19% to $114648.7 in 2019.
• Business Quant data shows KZIA's Long-Term Investments at $114648.7 in Q4 2019, $117679.3 in Q2 2019, and $2.0 million in Q4 2018.